companydata.dkcompanydata.dk

BIOPORTO DIAGNOSTICS A/S: Financial statements 2015

CVR: 18645882

Source: annual report 2015, Danish Business Authority

01/01/2015 – 31/12/2015

BIOPORTO DIAGNOSTICS A/S (CVR 18645882) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 20,383,088 and a net result of DKK -17,453,206 compared with DKK -22,756,940 the year before. That is an increase of 9% compared with the year before. The profit margin was -85.6%. Equity in the 2015 report amounted to DKK -187,891,789. The company had 17 employees in the financial year.

Revenue
DKK 20,383,088
Gross Profit
DKK 5,537,260
Profit/Loss
DKK -17,453,206
Equity
DKK -187,891,789
Total Assets
DKK 14,060,698
Employees
17

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
201520.4 mio.5.5 mio.-17.5 mio.-187.9 mio.17
201418.7 mio.4.6 mio.-22.8 mio.-170.4 mio.-
201316.6 mio.-1.2 mio.-20.6 mio.-146.4 mio.-
201217.9 mio.11.1 mio.-15.1 mio.-125.8 mio.20

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is BIOPORTO DIAGNOSTICS A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2015

BIOPORTO DIAGNOSTICS A/S: The 2014 annual report is outMay 29, 2015

BIOPORTO DIAGNOSTICS A/S has published its annual report for 2014. Revenue came to DKK 18,705,411, and the net result was DKK -22,756,940.

Otto Christian Aagaard Rasmussen steps down as økonomidirektør of BIOPORTO DIAGNOSTICS A/SJan 16, 2015

As of January 16, 2015, Otto Christian Aagaard Rasmussen has stepped down as økonomidirektør of BIOPORTO DIAGNOSTICS A/S.

About BIOPORTO DIAGNOSTICS A/S

BIOPORTO DIAGNOSTICS A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 1995. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ANTIBODYSHOP A/S and IMMUNOLEX ApS. The management consists of Carsten Buhl. The board consists of Gry Louise Husby Larsen (chair), Carsten Buhl and Klaus Juhl Wulff. The company is owned by BIOPORTO A/S. The company has 29 employees (2026). In 2025, the company reported revenue of DKK 40,286,970 and a net result of DKK -81,398,096 compared with DKK -110,908,377 the year before. Equity in the 2025 report amounted to DKK -837,580,713.

Source: annual report 2025, Danish Business Authority